A review of the anti-tumor potential of current therapeutics targeting the mitochondrial protease ClpP in H3K27-altered, diffuse midline glioma.

Jackson, Evangeline R; Persson, Mika L; Fish, Cameron J; Findlay, Izac J; Mueller, Sabine; Nazarian, Javad; Hulleman, Esther; van der Lugt, Jasper; Duchatel, Ryan J; Dun, Matthew D.

Afiliação

Jackson ER; Cancer Signalling Research Group, School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, NSW, Australia.
Persson ML; Precision Medicine Research Program, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia.
Fish CJ; Cancer Signalling Research Group, School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, NSW, Australia.
Findlay IJ; Precision Medicine Research Program, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia.
Mueller S; Cancer Signalling Research Group, School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, NSW, Australia.
Nazarian J; Precision Medicine Research Program, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia.
Hulleman E; Cancer Signalling Research Group, School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, NSW, Australia.
van der Lugt J; Precision Medicine Research Program, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia.
Duchatel RJ; DIPG/DMG Center Zurich, University Children's Hospital Zürich, Zurich, Switzerland.
Dun MD; Department of Neurology, Neurosurgery and Pediatric, UCSF, San Francisco, CA, USA.